| dbo:abstract
|
- Oxilofrin (Handelsname: Carnigen) ist ein Arzneistoff aus der Gruppe der Sympathomimetika, der zur Behandlung des erniedrigten Blutdrucks (orthostatische Hypotonie) angewandt wird. (de)
- Oxilofrine (also known as methylsynephrine, hydroxyephrine, oxyephrine, and 4-HMP) is a stimulant drug and is an amphetamine chemically related to ephedrine and to synephrine. Oxilofrine is currently a World Anti-Doping Agency (WADA) prohibited substance when used in competition. It has been found as an adulterant in some dietary supplements. Even after receiving warning letters from the FDA, some sports and weight loss supplement companies continue to use oxilofrine as an undeclared ingredient in their products despite it being prohibited. (en)
- Oxilofrine (4-Hydroxyefedrin, ) was tussen 1950 en 2010 in Duitsland in de handel als geneesmiddel tegen een te lage bloeddruk. De handelsnaam was Carnigen® en het bevat oxilofrinehydrochloride in de sterktes van 16 en 32 mg. Het is een hydroxyl-derivaat van efedrine. Het werkt als sympathicomimeticum. In juli 2013 kwam het in het nieuws als nieuw ontdekt dopingmiddel. Het zou onderdeel zijn van het voedingssupplement Nutrex. In 2014 werd oxilofrine aangetroffen in het supplement Dexaprine nadat er tientallen bijwerkingen waren gemeld. Dexaprine bevatte naast oxilofrine ook deterenol en BMPEA derivaten. Oxilofrine is verwant aan efedrine en synefrine. In tegenstelling tot efedrine kunnen oxilofrine en synefrine niet doordringen tot de hersenen en werken alleen op hart- en bloedvaten. Sinds 2008 staan deze stoffen toch weer op de dopinglijst van WADA (nl)
- Oxilofrina (também conhecida como metilsinefrina, hidroxiefrina, oxiefrina e 4-HMP) é uma droga estimulante, da classe das anfetaminas, quimicamente relacionada à efedrina e à sinefrina. A oxilofrina é uma substância proibida pela Agência Mundial Antidoping (WADA) em competições. Foi encontrada como adulterante em alguns suplementos alimentares. Mesmo após a carta de advertência emitida pela Food and Drug Administration (FDA) para que o fármaco fosse retirado do mercado, algumas empresas de suplementos esportivos e perda de peso continuam a usar a oxilofrina como um princípio ativo não declarado em seus produtos. (pt)
|
| dbo:casNumber
| |
| dbo:chEMBL
| |
| dbo:drugbank
| |
| dbo:fdaUniiCode
| |
| dbo:kegg
| |
| dbo:pubchem
| |
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 11468 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:atcPrefix
| |
| dbp:c
| |
| dbp:casNumber
| |
| dbp:chembl
| |
| dbp:chemspiderid
| |
| dbp:drugbank
| |
| dbp:h
| |
| dbp:iupacName
| |
| dbp:kegg
| |
| dbp:legalStatus
| |
| dbp:n
| |
| dbp:o
| |
| dbp:pubchem
| |
| dbp:stdinchi
| |
| dbp:stdinchikey
|
- OXFGTKPPFSCSMA-UHFFFAOYSA-N (en)
|
| dbp:unii
| |
| dbp:verifiedfields
| |
| dbp:verifiedrevid
| |
| dbp:watchedfields
| |
| dbp:width
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- Oxilofrin (Handelsname: Carnigen) ist ein Arzneistoff aus der Gruppe der Sympathomimetika, der zur Behandlung des erniedrigten Blutdrucks (orthostatische Hypotonie) angewandt wird. (de)
- Oxilofrine (also known as methylsynephrine, hydroxyephrine, oxyephrine, and 4-HMP) is a stimulant drug and is an amphetamine chemically related to ephedrine and to synephrine. Oxilofrine is currently a World Anti-Doping Agency (WADA) prohibited substance when used in competition. It has been found as an adulterant in some dietary supplements. Even after receiving warning letters from the FDA, some sports and weight loss supplement companies continue to use oxilofrine as an undeclared ingredient in their products despite it being prohibited. (en)
- Oxilofrina (também conhecida como metilsinefrina, hidroxiefrina, oxiefrina e 4-HMP) é uma droga estimulante, da classe das anfetaminas, quimicamente relacionada à efedrina e à sinefrina. A oxilofrina é uma substância proibida pela Agência Mundial Antidoping (WADA) em competições. Foi encontrada como adulterante em alguns suplementos alimentares. Mesmo após a carta de advertência emitida pela Food and Drug Administration (FDA) para que o fármaco fosse retirado do mercado, algumas empresas de suplementos esportivos e perda de peso continuam a usar a oxilofrina como um princípio ativo não declarado em seus produtos. (pt)
- Oxilofrine (4-Hydroxyefedrin, ) was tussen 1950 en 2010 in Duitsland in de handel als geneesmiddel tegen een te lage bloeddruk. De handelsnaam was Carnigen® en het bevat oxilofrinehydrochloride in de sterktes van 16 en 32 mg. Het is een hydroxyl-derivaat van efedrine. Het werkt als sympathicomimeticum. Oxilofrine is verwant aan efedrine en synefrine. In tegenstelling tot efedrine kunnen oxilofrine en synefrine niet doordringen tot de hersenen en werken alleen op hart- en bloedvaten. Sinds 2008 staan deze stoffen toch weer op de dopinglijst van WADA (nl)
|
| rdfs:label
|
- Oxilofrin (de)
- Oxilofrine (en)
- Oxilofrine (nl)
- Oxilofrina (pt)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
